T. Lucas-Morante

Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma.

B. Ponder, J. Benítez, R. Milne, 2005, The Journal of clinical endocrinology and metabolism.

SDHD Variants Do Not Constitute a Risk Factor for Developing C-Cell Hyperplasia, or Sporadic Medullary Thyroid Carcinoma

Melchor Fernández Almagro, B. Ponder, J. Benítez, 2004 .

The Molecular Registry of Pituitary Adenomas (REMAH): A bet by Spanish Endocrinology for the future of individualized medicine and translational research

S. Gaztambide, M. Puig-Domingo, M. Marazuela, 2016 .

The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.

S. Gaztambide, M. Puig-Domingo, M. Marazuela, 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas

M. Puig-Domingo, M. Marazuela, I. Bernabéu, 2011 .

Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).

S. Gaztambide, M. Catalá, R. Astorga, 2004, European journal of endocrinology.

Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery.

A. Cabello, B. Barceló, J. Estrada, 1994, Journal of neurosurgery.